Veracyte (VCYT) Asset Writedowns and Impairment (2016 - 2025)
Veracyte (VCYT) has disclosed Asset Writedowns and Impairment for 10 consecutive years, with -$5000.0 as the latest value for Q4 2025.
- Quarterly Asset Writedowns and Impairment fell 100.18% to -$5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.5 million through Dec 2025, up 508.52% year-over-year, with the annual reading at $20.5 million for FY2025, 508.67% up from the prior year.
- Asset Writedowns and Impairment hit -$5000.0 in Q4 2025 for Veracyte, down from $20.5 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $34.9 million in Q3 2023 to a low of -$5000.0 in Q4 2025.
- Historically, Asset Writedowns and Impairment has averaged $10.6 million across 4 years, with a median of $2.8 million in 2024.
- Biggest five-year swings in Asset Writedowns and Impairment: crashed 69.57% in 2024 and later tumbled 100.18% in 2025.
- Year by year, Asset Writedowns and Impairment stood at $3.3 million in 2022, then surged by 865.61% to $32.0 million in 2023, then plummeted by 91.4% to $2.8 million in 2024, then tumbled by 100.18% to -$5000.0 in 2025.
- Business Quant data shows Asset Writedowns and Impairment for VCYT at -$5000.0 in Q4 2025, $20.5 million in Q2 2025, and $2.8 million in Q4 2024.